Skip to main content
OpenTrials

Clinical trial condition

Tuberculosis, Multidrug-Resistant

Explore clinical trials studying Tuberculosis, Multidrug-Resistant. Study availability and eligibility vary by location and protocol.

102 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Tuberculosis, Multidrug-Resistant trial results

Completed

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

NCT03830671

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • Beijing Chest Hospital Beijing, China
  • The 8th Medical Center of Chinese Pla General Hospital Beijing, China
  • Changchun Infectious Disease Hospital Changchun, China
  • Hunan Institute For Tuberculosis Control Changsha, China
View all 20 locations
View Trial Details
Completed

Expand New Drugs for TB [endTB]

NCT03259269

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • National Treatment Centre for Tuberculosis, Abovian, Armenia Abovyan, Armenia
  • National Institute of Diseases of the Chest and Hospital (NIDCH), Dhaka Dhaka, Bangladesh
  • Republican Research and Practical Centre for Pulmonology and Tuberculosis Minsk, Belarus
  • Aung San Tuberculosis Hospital Yangon, Burma
View all 16 locations
View Trial Details
Completed

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

NCT02607449

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • Semey Medical University Semey, East Kazakhstan, Kazakhstan
  • West Kazakhstan Marat Ospanov Medical University Aktobe, West Kazakhstan, Kazakhstan
  • National scientific center of phthisiopulmonology Ministry of health of the Republic of Kazakhstan Almaty, Kazakhstan
  • Center of Phthisiopulmonology of the Public Health Administration of Almaty Almaty, Kazakhstan
View Trial Details
Completed

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

NCT00685360

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +11 more
Locations
  • University of Texas Health Center at Tyler / Heartland National TB Center / Texas Center for Infectious Disease San Antonio, Texas, United States
  • Beijing Chest Hospital Beijing, China
  • Shanghai Pulmonary Hospital Shanghai, China
  • Abbassia Chest Hospital Cairo, Egypt
View all 17 locations
View Trial Details
Completed

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

NCT02573350

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • Beijing Chest Hospital Beijing, China
  • North Estonian Medical Centre Foundation Center of Pulmonology Tallinn, Estonia
  • Tartu University Lung Hospital Tartu, Estonia
  • State Agency of Tuberculosis and Lung Disease Riga, Latvia
View Trial Details

Related conditions